Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,954 | -1,513 | -786 | -3,329 | -2,475 |
| Depreciation Amortization | 8 | 5 | 2 | 78 | 75 |
| Other Working Capital | 298 | 172 | 97 | 319 | 58 |
| Other Operating Activity | -1,640 | -4,330 | -4,100 | 14,367 | -2,048 |
| Operating Cash Flow | $-4,288 | $-5,666 | $-4,787 | $11,435 | $-4,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -12 | -3 | 225 | 225 |
| Other Investing Activity | -129 | -99 | -53 | 936 | 969 |
| Investing Cash Flow | $-148 | $-111 | $-56 | $1,161 | $1,194 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -13,954 | -13,954 | -13,956 | -49 | -49 |
| Other Financing Activity | 0 | 0 | 0 | -284 | 0 |
| Financing Cash Flow | $-13,954 | $-13,954 | $-13,956 | $-333 | $-49 |
| Beginning Cash Position | 20,946 | 20,946 | 20,946 | 8,683 | 8,683 |
| End Cash Position | 2,556 | 1,215 | 2,147 | 20,946 | 5,438 |
| Net Cash Flow | $-18,390 | $-19,731 | $-18,799 | $12,263 | $-3,245 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,288 | -5,666 | -4,787 | 11,435 | -4,390 |
| Capital Expenditure | -19 | -12 | -3 | N/A | N/A |
| Free Cash Flow | -4,307 | -5,678 | -4,790 | 11,435 | -4,390 |